Background & aims: This study is focused on the impact of enteral immunonutrition on the cell-mediated immune response in the microenvironment of gastric and colorectal cancers. Methods: This is a prospective pilot study approved by the local Ethics Committee. The immunophenotypic structure of the immune cells before (on the biopsy) and after (on the surgical sample) the administration of the immunonutrition in 16 patients is compared with 8 patients receiving regular diet. The samples of non-tumour tissue from sleeve-gastrectomy are used as non-neoplastic control. Antibodies were tested: CD4, CD8, PD-1, FOX-P3, CD68, CD163, CD80, CD21, CD56, PD-L1. We applied already well-known scoring systems for the evaluation of the immunohistochemi...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
Key words: gastric cancer; colorectal cancer; lymphocyte subsets; immune system. Summary. The aim of...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
Background & aims: This study is focused on the impact of enteral immunonutrition on the cell-me...
Background & aims: This study is focused on the impact of enteral immunonutrition on the cell-me...
Enteral immunodiet has been gaining increasing attention, but experimental data of its clinical effe...
Enteral immunodiet has been gaining increasing attention, but experimental data of its clinical effe...
Enteral immunodiet has been gaining increasing attention, but experimental data of its clinical effe...
To evaluate the influence of postoperative immunonutrition on immune and nutritional parameters in p...
ObjectiveTo evaluate the influence of postoperative immunonutrition on immune and nutritional parame...
Objective: To explore the effect of surgical treatment on the anti-tumor immune function in patient...
Purpose of review The growing awareness that the immune system is a key player in the antitumoral re...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
Key words: gastric cancer; colorectal cancer; lymphocyte subsets; immune system. Summary. The aim of...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
Background & aims: This study is focused on the impact of enteral immunonutrition on the cell-me...
Background & aims: This study is focused on the impact of enteral immunonutrition on the cell-me...
Enteral immunodiet has been gaining increasing attention, but experimental data of its clinical effe...
Enteral immunodiet has been gaining increasing attention, but experimental data of its clinical effe...
Enteral immunodiet has been gaining increasing attention, but experimental data of its clinical effe...
To evaluate the influence of postoperative immunonutrition on immune and nutritional parameters in p...
ObjectiveTo evaluate the influence of postoperative immunonutrition on immune and nutritional parame...
Objective: To explore the effect of surgical treatment on the anti-tumor immune function in patient...
Purpose of review The growing awareness that the immune system is a key player in the antitumoral re...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...
Key words: gastric cancer; colorectal cancer; lymphocyte subsets; immune system. Summary. The aim of...
The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmar...